Norges Bank Veracyte, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$18.86 - $23.55 $2.95 Million - $3.68 Million
156,402 New
156,402 $3.39 Million
Q4 2023

Feb 09, 2024
BUY
$19.72 - $28.68 $8.02 Million - $11.7 Million
406,749 New
406,749 $11.2 Million
Q3 2023

Nov 13, 2024
BUY
$22.33 - $29.92 $10.3 Million - $13.8 Million
462,140 New
462,140 $10.3 Million
Q3 2023

Nov 13, 2023
SELL
$22.33 - $29.92 $7.01 Million - $9.39 Million
-313,705 Closed
0 $0
Q2 2023

Aug 14, 2024
BUY
$20.96 - $26.99 $997,297 - $1.28 Million
47,581 Added 30.42%
203,983 $5.2 Million
Q2 2023

Aug 14, 2023
SELL
$20.96 - $26.99 $9.91 Million - $12.8 Million
-472,799 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$20.58 - $27.89 $9.97 Million - $13.5 Million
484,283 New
484,283 $10.8 Million
Q4 2022

Feb 14, 2023
BUY
$15.31 - $29.94 $5.8 Million - $11.3 Million
378,828 New
378,828 $8.99 Million
Q3 2022

Nov 13, 2023
BUY
$16.58 - $27.9 $5.2 Million - $8.75 Million
313,705 New
313,705 $5.21 Million
Q2 2022

Aug 14, 2023
BUY
$15.45 - $29.52 $7.3 Million - $14 Million
472,799 New
472,799 $9.41 Million
Q1 2022

May 12, 2023
BUY
$21.94 - $42.51 $2.86 Million - $5.53 Million
130,173 Added 34.36%
509,001 $14 Million
Q1 2022

May 09, 2022
SELL
$21.94 - $42.51 $7.08 Million - $13.7 Million
-322,801 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$36.09 - $53.79 $11.6 Million - $17.4 Million
322,801 New
322,801 $13.3 Million
Q3 2021

Nov 14, 2022
BUY
$35.62 - $52.97 $17.3 Million - $25.7 Million
485,001 New
485,001 $22.5 Million
Q3 2021

Nov 05, 2021
SELL
$35.62 - $52.97 $19.5 Million - $29.1 Million
-548,519 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$32.94 - $56.62 $18.1 Million - $31.1 Million
548,519 New
548,519 $21.9 Million
Q2 2021

Aug 10, 2021
SELL
$32.94 - $56.62 $17.9 Million - $30.8 Million
-544,459 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$44.47 - $81.38 $24.2 Million - $44.3 Million
544,459 New
544,459 $29.3 Million
Q1 2021

May 07, 2021
SELL
$44.47 - $81.38 $1.16 Million - $2.12 Million
-26,006 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$32.49 - $61.88 $844,934 - $1.61 Million
26,006 New
26,006 $1.27 Million
Q1 2020

May 08, 2020
SELL
$16.13 - $30.17 $645,200 - $1.21 Million
-40,000 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$20.78 - $29.99 $831,200 - $1.2 Million
40,000 New
40,000 $1.12 Million
Q4 2019

Feb 12, 2020
SELL
$20.78 - $29.99 $831,200 - $1.2 Million
-40,000 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$23.87 - $30.93 $954,800 - $1.24 Million
40,000 New
40,000 $960,000
Q3 2019

Nov 08, 2019
SELL
$23.87 - $30.93 $954,800 - $1.24 Million
-40,000 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$22.1 - $28.56 $884,000 - $1.14 Million
40,000 New
40,000 $1.14 Million

Others Institutions Holding VCYT

# of Institutions
307
Shares Held
81.6M
Call Options Held
134K
Put Options Held
13.3K
View Full List

About VERACYTE, INC.

VCYT Quotes by TradingView
  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.97B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email